Slippery Slope: Binge Eating Dx -- Gateway to Off-Label?

In addition to a flurry of new weight-loss drugs, the U.S. Food and Drug Administration recently authorized the use of an ADHD drug to treat binge-eating disorder -- a diagnosis that is rejected by some medical professionals. The condition, characterized by compulsive overeating, achieved legitimacy when it was included in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders. If an amphetamine is approved for binge-eating, will it be used off-label for weight loss? http://www.medpagetoday.com/special-reports/slipperyslope/51056?xid=nl_mpt_DHE_2015-04-20&eun=g721819d0r&userid=721819&mu_id=5883165